Serum bone metabolism biomarkers in healthy filies and colts from weaning until one year of age. (5th December 2022) - Arfuso, Francesca
Abstract: This study aimed to investigate the serum concentration of osteocalcin (OC), parathyroid hormone (PTH), calcitonin (CT), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP) and acid phosphatase (AP) in healthy-weaned-foals from 8 months of age until the first year of life. Moreover, the correlation of investigated parameters and foals' age, as well as the relationship between the serum values of PTH and the other markers of bone remodeling were assessed. From 20 foals (10 fillies, 10 colts), blood samples were monthly collected (from 8 to 12 months of age, T1-T5) and the concentration of OC, CT, Ca, P, ALP, AP and PTH was assessed. Two-way repeated measures analysis of variance (ANOVA) showed age-related differences on OC concentration in both fillies ( P = 0.008) and colts ( P = 0.03) with higher OC values at T5 than T1 and T2. Sex-related effect on OC concentration was found with higher OC levels in colts compared to fillies ( P = 0.01). A significant positive correlation between the OC, PTH, CT and APL values and foal's age was found in fillies and colts. PTH levels were positively correlated with the values of OC in fillies and colts. Obtained findings confirmed the dynamic bone turnover during growth in foals. The modification of PTH and OC confirmed the potential role of these parameters as indicator of bone growth and metabolism. The sex-related difference observed in OC concentration opens up new insights into the possible involvement of sex hormones in the regulation of bone metabolism in prepubertal foals. Highlights: Serum bone metabolism biomarkers are studied in foals from 8 months of age up to the first year of life. Age-related changes on osteocalcin values are observed in both fillies and colts. Osteocalcin values were higher in colts compared to fillies. Parathyroid hormone was positively correlated with osteocalcin values in fillies and colts. Study confirms role of parathyroid hormone and osteocalcin as bone growth/metabolism indicators.